Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,000 | 163,700 | N/A | 93,200 | 110,900 |
| Marketable Securities | 33,700 | 54,100 | N/A | 43,700 | 69,700 |
| Receivables | 89,500 | 71,000 | N/A | 138,600 | 103,300 |
| Inventories | 27,100 | 29,100 | N/A | 31,400 | 34,300 |
| TOTAL | $389,400 | $331,700 | $N/A | $348,600 | $327,600 |
| Non-Current Assets | |||||
| PPE Net | 40,700 | 37,000 | N/A | 57,300 | 43,200 |
| Investments And Advances | 21,000 | 37,000 | 0 | 54,900 | 30,700 |
| Intangibles | 905,700 | 932,900 | 0 | 1,101,900 | 773,800 |
| Other Non-Current Assets | 62,000 | 66,000 | 0 | 0 | 0 |
| TOTAL | $1,029,400 | $1,072,900 | $N/A | $1,214,100 | $847,700 |
| Total Assets | $1,418,800 | $1,404,600 | $N/A | $1,562,700 | $1,175,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,500 | 21,700 | 0 | 33,300 | 26,000 |
| Accrued Expenses | 79,100 | 75,900 | N/A | 78,900 | 68,300 |
| Other current liabilities | N/A | 3,100 | N/A | 3,400 | 5,300 |
| TOTAL | $145,900 | $147,000 | $N/A | $117,800 | $102,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 224,800 | 224,400 | N/A | 233,500 | 9,300 |
| Deferred Revenues | 32,700 | 32,800 | N/A | 2,200 | 2,600 |
| Other Non-Current Liabilities | 95,800 | 88,500 | 0 | 40,100 | 40,600 |
| TOTAL | $391,900 | $339,400 | $N/A | $356,000 | $107,000 |
| Total Liabilities | $537,800 | $486,400 | $N/A | $473,800 | $209,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 74,550 | N/A | N/A |
| Common Shares | 800 | 700 | N/A | 700 | 700 |
| Retained earnings | -227,000 | -173,900 | N/A | 25,600 | 54,100 |
| Other shareholders' equity | -2,300 | -5,200 | 0 | -5,400 | -4,100 |
| TOTAL | $881,000 | $918,200 | $N/A | $1,088,900 | $966,100 |
| Total Liabilities And Equity | $1,418,800 | $1,404,600 | $0 | $1,562,700 | $1,175,300 |